Are You And Your Primary Care Doc Ready To Talk About Your DNA?
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
All Coverage
-
-
When Is Insurance Not Really Insurance? When You Need Pricey Dental Care.
Even under a decent plan, you’ll have to dig deep in your pocket for crowns, bridges and implants. The mouth isn’t covered by insurance the same way as the rest of the body, and this division has deep roots in history and tradition.
-
Trump Proposes Cutting Planned Parenthood Funds. What Does That Mean?
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
-
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Readers And Tweeters Are Buzzing Over ‘Bill Of The Month’
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
-
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
-
Vermont Legislators Pass A Drug Importation Law. So What?
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
-
Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
-
What Explains The Rising Overdose Rate Among Latinos?
Opioid addiction is often portrayed as a white problem, but overdose rates are now rising faster among Latinos and blacks. Cultural and linguistic barriers may put Latinos at greater risk.
-
California’s Deadly STD Epidemic Sets Record
Rates of gonorrhea, syphilis and chlamydia in California have shot up 45 percent over five years, resulting in 30 syphilis-related stillbirths in 2017 alone, new state data show.
-
Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
-
California Hospital Giant Sutter Health Faces Heavy Backlash On Prices
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
-
Lack Of Insurance Exposes Blind Spots In Vision Care
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
-
Will We Still Be Relevant ‘When We’re 64’?
Older adults often feel invisible as their interactions with younger people dwindle and hardly anyone seems to seek their advice. To make matters worse, studies link loneliness to weaker immune systems and poorer physical health.
-
Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
-
First, Marijuana. Are Magic Mushrooms Next?
Advocates in Oregon and Denver are pushing ballot measures to allow possession of mushrooms containing the hallucinogenic ingredient psilocybin, as new research shows it may be useful in treating depression and anxiety. Supporters of a measure to decriminalize magic mushrooms in California ended their effort late last month.
-
L.A. County Unlawfully Terminated Thousands Of Medi-Cal Recipients, Court Rules
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
-
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
-
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Why Did Novartis Pay Trump’s Lawyer $1.2 Million? Look At Its Drug Prices
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
